Praxis Precision Medicines, Inc.·4

Jan 17, 7:38 PM ET

Sweeny Nicole 4

4 · Praxis Precision Medicines, Inc. · Filed Jan 17, 2023

Insider Transaction Report

Form 4
Period: 2023-01-12
Sweeny Nicole
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-12+120,000120,000 total
    Exercise: $2.96Exp: 2033-01-12Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.

Documents

1 file
  • 4
    wf-form4_167400228292631.xmlPrimary

    FORM 4